A new preclinical study from Weill Cornell Medicine found that the protein caspase-5 (CASP5), long thought to be a foot ...

A new preclinical study from Weill Cornell Medicine found that the protein caspase-5 (CASP5), long thought to be a foot soldier in the body's defense ...

Iterion Therapeutics announced that two abstracts featuring its first-in-class TBL1 inhibitor, tegavivint, will be presented at the 2026 American Association for Cancer Research (AACR) Annual Meeting.

New AACR data highlight stenoparib’s potential in colorectal cancer through WNT pathway modulationThe Stenoparib-DRP® companion ...

A research team has discovered a new mechanism and drug combination strategy that can effectively treat osteoporosis, a ...

Researchers are rethinking how we target bowel cancer growth pathways, using patient-derived organoids to identify whether ...

Seoul National University College of Engineering (SNU Engineering) announced that a joint research team led by Prof. Sunghoon ...

Surrozen, Inc. (SRZN) shares rallied 5.9% in the last trading session to close at $29.86. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...

Cancer stem cells (CSCs), a critical subpopulation within tumors, drive cancer initiation, progression, metastasis, relapse, ...

Cancer stem cells (CSCs), a critical subpopulation within tumors, drive cancer initiation, progression, metastasis, relapse, ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of a pivotal Phase 2b/3 trial evaluating MK-8748 (also known as Tiespectus, EYE201), a novel ...